Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The current landscape of therapies for hepatocellular carcinoma.
Carcinogenesis. 2023 Oct 20;44(7):537-548. doi: 10.1093/carcin/bgad052.
Carcinogenesis. 2023.
PMID: 37428789
Review.
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer.
Monge C, Xie C, Myojin Y, Coffman K, Hrones DM, Wang S, Hernandez JM, Wood BJ, Levy EB, Juburi I, Hewitt SM, Kleiner DE, Steinberg SM, Figg WD, Redd B, Homan P, Cam M, Ruf B, Duffy AG, Greten TF.
Monge C, et al. Among authors: hrones dm.
J Immunother Cancer. 2023 Feb;11(2):e005640. doi: 10.1136/jitc-2022-005640.
J Immunother Cancer. 2023.
PMID: 36754451
Free PMC article.
Clinical Trial.
Item in Clipboard
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial.
Coffman-D'Annibale K, Myojin Y, Monge C, Xie C, Hrones DM, Wood BJ, Levy EB, Kleiner D, Figg WD, Steinberg SM, Redd B, Greten TF.
Coffman-D'Annibale K, et al. Among authors: hrones dm.
J Immunother Cancer. 2024 Jan 6;12(1):e008079. doi: 10.1136/jitc-2023-008079.
J Immunother Cancer. 2024.
PMID: 38184304
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite